1.Baicalein Inhibits the Migration and Invasion of B16F10 Mouse Melanoma Cells through Inactivation of the PI3K/Akt Signaling Pathway.
Eun Ok CHOI ; Eun Ju CHO ; Jin Woo JEONG ; Cheol PARK ; Su Hyun HONG ; Hye Jin HWANG ; Sung Kwon MOON ; Chang Gue SON ; Wun Jae KIM ; Yung Hyun CHOI
Biomolecules & Therapeutics 2017;25(2):213-221
Baicalein, a natural flavonoid obtained from the rhizome of Scutellaria baicalensis Georgi, has been reported to have anticancer activities in several human cancer cell lines. However, its antimetastatic effects and associated mechanisms in melanoma cells have not been extensively studied. The current study examined the effects of baicalein on cell motility and anti-invasive activity using mouse melanoma B16F10 cells. Within the noncytotoxic concentration range, baicalein significantly inhibited the cell motility and invasiveness of B16F10 cells in a concentration-dependent manner. Baicalein also reduced the activity and expression of matrix metalloproteinase (MMP)-2 and -9; however, the levels of tissue inhibitor of metalloproteinase-1 and -2 were concomitantly increased. The inhibitory effects of baicalein on cell motility and invasiveness were found to be associated with its tightening of tight junction (TJ), which was demonstrated by an increase in transepithelial electrical resistance and downregulation of the claudin family of proteins. Additionally, treatment with baicalein markedly reduced the expression levels of lipopolysaccharide-induced phosphorylated Akt and the invasive activity in B16F10 cells. Taken together, these results suggest that baicalein inhibits B16F10 melanoma cell migration and invasion by reducing the expression of MMPs and tightening TJ through the suppression of claudin expression, possibly in association with a suppression of the phosphoinositide 3-kinase/Akt signaling pathway.
Animals
;
Cell Line
;
Cell Movement
;
Down-Regulation
;
Electric Impedance
;
Humans
;
Matrix Metalloproteinases
;
Melanoma*
;
Mice*
;
Rhizome
;
Scutellaria baicalensis
;
Tight Junctions
;
Tissue Inhibitor of Metalloproteinase-1
2.Chinese Herbs Induced End-Stage Renal Disease in a Patient with Minimal Change Nephrotic Syndrome.
Hye Young SUNG ; Seok Jun SHIN ; Sang Won SON ; Jae Gue JUNG ; Se Na JANG ; Joo Ho HAM ; Sang Mi PARK ; Ho Cheol SONG ; Euy Jin CHOI ; Yoon Sik CHANG
Korean Journal of Nephrology 2006;25(1):99-102
An outbreak of rapidly progressive renal failure was observed in Belgium in 1993 and was related to a slimming regimen involving Chinese herbs. Extensive interstitial fibrosis with atrophy and tubular loss was the major histological lesion. Aristolochic acid has been suspected to be responsible for nephrotoxicity. The use of Chinese herbal medicines is very popular in Korea. We report the presence of a nephrotoxic compound in herb medications, which led to end-stage renal failure in a patient with complete remission state of minimal change disease. The typical and sequential pathologic changes in our patient following the consumption of herbs suggest possible relationship to herbal medicines, and end-stage renal disease, despite the fact that a cause-and-effect relationship cannot be automatically inferred.
Asian Continental Ancestry Group*
;
Atrophy
;
Belgium
;
Fibrosis
;
Humans
;
Kidney Failure, Chronic*
;
Korea
;
Nephrosis
;
Nephrosis, Lipoid*
;
Renal Insufficiency
4.Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines.
Ga-Young LEE ; Jin-Seok LEE ; Chang-Gue SON ; Nam-Hun LEE
Chinese journal of integrative medicine 2021;27(7):551-560
Colorectal cancer (CRC) is one of the most prevalent and lethal cancer types around the world. Most of the CRC patients are treated with chemotherapeutic drugs alone or combined. However, up to 90% of metastatic cancer patients experience the failure of treatment mostly because of the acquired drug resistance, which can be led to multidrug resistance (MDR). In this study, we reviewed the recent literature which studied potential CRC MDR reversal agents among herbal medicines (HMs). Among abundant HMs, 6 single herbs, Andrographis paniculata, Salvia miltiorrhiza, Hedyotis diffusa, Sophora flavescens, Curcuma longa, Bufo gargarizans, and 2 formulae, Pien Tze Huang and Zhi Zhen Fang, were found to overcome CRC MDR by two or more different mechanisms, which could be a promising candidate in the development of new drugs for adjuvant CRC chemotherapy.